Axcel CV K/S · CIK 2071644
Axcel CV K/S
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
Filings
1
Original notices
1
Amendments
0
Activity
Jun 6, 2025
through Jun 6, 2025
through Jun 6, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- —
- Reported exemptions
- Rule 506(b), Investment Company Act Section 3(c), Investment Company Act Section 3(c)(1), Investment Company Act Section 3(c)(7)
- Reported amount sold
- $51,432,121
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Related person name and locality match
Matches in stored disclosures are research leads. They do not establish common ownership or confirm identity.
- Axcel Elevate I K/S · CIK 2083802
- Axcel Elevate I K/S 2 · CIK 2083803
- Axcel VIII K/S · CIK 2120440
- Axcel VIII K/S 2 · CIK 2120436
Same reported sales compensation recipient
Matches in stored disclosures are research leads. They do not establish common ownership or confirm identity.
- 3|5|2 Capital ABS Fund LLC · CIK 1857254
- Aadi Bioscience, Inc. · CIK 1422142
- Anchorage CV-PC, L.P. · CIK 2097456
- BlackRock Direct Lending Fund 2025-C, L.P. · CIK 2079596
- BlackRock Direct Lending Fund 2025-C PF, L.P. · CIK 2075040
Form D filings (1)
-
0002071644-25-000001D · Jun 6, 2025 · Pooled Investment FundSold: $51,432,121